EMCDDA Home
  • EN
Search

Table GPS-3. Last 30 days prevalence of drug use by age and country, most recent national general population survey available since 2000 [see all tables in this series...]

Part (iii) Youth (aged 15–24)

CountryGeographical areaYearReferenceAge range Sample size (15–24)Cannabis (%)Cocaine (%) (1)Amphetamines (%) (2)Ecstasy (%) (3)LSD (%)
BelgiumNational2008(7)15–2412106.6::::
BulgariaNational2008(3)15–2410874.91.11.41.30.1
Czech Republic(4)National2009(5)15–2427511.60.00.00.7:
DenmarkNational2010(6)16–2416717.10.91.00.30.1
GermanyNational2009(8)18–24:7.00.51.40.40.2
EstoniaNational2008(3)15–242435.30.32.31.00.0
IrelandNational2006–07(5)15–24:5.31.10.21.00.1
GreeceNational (except Aegean and Ionian Islands)2004(3)15–2417851.20.10.10.10.0
SpainNational2009(8)15–24:17.21.81.01.1:
FranceNational2005(6)15–24466212.70.40.10.30.1
ItalyNational2008(4)15–24347511.01.00.20.4:
CyprusNational2009(2)15–249823.91.10.40.80.4
LatviaNational2007(2)15–2418554.00.50.30.90.1
LithuaniaNational2008(2)15–2411653.60.00.40.70.1
Luxembourg::::::::::
HungaryNational2007(3)18–244334.60.51.10.50.0
MaltaNational2001(1)18–24287:::::
NetherlandsNational2005(3)15–24:5.3::::
AustriaNational2008(2)15–2420855.30.80.71.00.0
PolandNational2006(2)15–2411352.50.20.40.40.0
PortugalNational2007(2)15–2422114.10.20.10.40.0
RomaniaNational2007(2)15–2410600.50.00.00.10.0
SloveniaNational2007(1)15–24338:::::
SlovakiaNational2006(6)15–242876.00.70.71.8:
FinlandNational2006(7)15–246544.40.60.60.30.2
SwedenNational2008(5)15–2477872.10.20.10.1:
SwedenNational2010(12)16–2410232.2::::
United KingdomEngland and Wales2009-10(13)16–2434299.22.60.71.90.2
United KingdomNorthern Ireland2008-09(18)16–242866.71.70.52.21.2
United KingdomScotland2008-09(22)16–24100410.64.21.12.30.4
United KingdomUnited Kingdom2006(24)16–24:12.13.41.32.70.0
Croatia::::::::::
Turkey::::::::::
NorwayNational2009(3)15–243902.30.30.20.00.0

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 (4) The most recent General population surveys reported by the Czech Republic display a wide variation in results, the reason for which is being explored, but may be due to differing sampling methods. The data is provided for information, but given the lack of comparability between surveys should be treated with caution. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions

 For methods of each survey presented in this table, see Table GPS-7 part (i).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page

                        

Sources:

 See Table GPS-0

(see the help page for information about formats etc.)

Page last updated: Thursday, 14 July 2011